Category: Pharmaceutical Fraud

Not All Financial Assistance from Drug Companies Is Considered an Illegal Kickback, Says the OIG

The devil is always in the details.  At the end of last year, the OIG issued an opinion (OIG Advisory Opinion No. 20-09) in response...

Study Shows Whistleblowers Help Curb Fraud

According to a study by Jaron H. Wilde at the University of Iowa (an assistant professor of accounting in the Tippie College of Business), whistleblowers...

Be More Than An Ethical Bystander: Become a Healthcare Whistleblower

With each New Year comes an avalanche of resolutions. We start afresh and then ease back into our old habits as the months pass. The...

Whistleblower Motivations

Nolan Auerbach & White 3 named partners themselves have collectively has represented the interests of whistleblowers for over 50 years! Thousands of potential healthcare whistleblowers...

Speaker Program Kickbacks: When Physicians Break the Law by Speaking for Pharmaceutical Manufacturers

https://youtu.be/JV1gy8aY36w Every single day across the country, physicians receive large speakers’ honoraria checks from pharmaceutical and medical device companies. These funds compensate the physicians for...

Speaker Program Kickbacks: Pharmaceutical Kickbacks Trigger False Claims Act Liability with Patients’ Lives in the Crosshairs

https://www.youtube.com/watch?v=5x0nK6DfPZM There are a number of kickbacks schemes that involve physicians. We are they are incentivized to write prescriptions for certain drugs. There are speaker...

Speaker Program Kickbacks: How Sham Physician Speaker Programs Fuel Sales of Prescription Drugs

https://youtu.be/YEEIenjvBHI We represent qui tam whistleblowers under the federal False Claims Act. The false claims act is an enormously effective and powerful law and provides...

Medical Device Manufacturers Marketing Pre-1976 Devices for Unapproved Uses

In 1976, Congress amended the FDCA to require any post-1976 devices to be approved via the rigorous Pre-Market Approval (PMA) process, unless the manufacturer could...

Daiichi Sankyo Whistleblower Case Returns Over $39 Million to the Government

We recently announced that Daiichi Sankyo had agreed to pay $39, 015, 770 plus interest to resolve our client’s lawsuit. The qui tam case was...

    Contact Us

    Contact Us

    The more detailed the response, the more likely it is that we will be able to evaluate and determine if your potential False Claims Act case falls within our case requirements. IF IT DOES, WE WILL RESPOND TO YOU WITHIN 24 HOURS. (Names of potential defendants are not necessary at this point, should you feel more comfortable omitting them.) By law, all communications to us are 100% confidential.

    No. of Employees at the Company?
    Please read the following statement and then click "Send Form":

    Any response to your e-mail will be solely to communicate about our possible representation of you under the qui tam provisions of the False Claims Act. All e-mails submitted to us, whether we take your case or not, are 100% confidential. If we do not respond to your e-mail, then you have communicated information which we cannot address because it appears to fall outside of the False Claims Act or our case requirements.